BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Xiong Y, Yu J. Modeling Parkinson's Disease in Drosophila: What Have We Learned for Dominant Traits? Front Neurol 2018;9:228. [PMID: 29686647 DOI: 10.3389/fneur.2018.00228] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Chen S, Li X, Xu Q, Lin Y, Lin F, Yuan M, Zi Y, Cai J. Progress in Parkinson's disease animal models of genetic defects: Characteristics and application. Biomedicine & Pharmacotherapy 2022;155:113768. [DOI: 10.1016/j.biopha.2022.113768] [Reference Citation Analysis]
2 Hegde KN, Srivastava A. Drosophila melanogaster as a Tool for Amyotrophic Lateral Sclerosis Research. JDB 2022;10:36. [DOI: 10.3390/jdb10030036] [Reference Citation Analysis]
3 Sanz FJ, Solana-Manrique C, Lilao-Garzón J, Brito-Casillas Y, Muñoz-Descalzo S, Paricio N. Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila. FASEB J 2022;36:e22432. [PMID: 35766235 DOI: 10.1096/fj.202200286R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gonçalves DF, Duarte T, Foletto JVP, Senger LR, Vargas Brabosa N, Soares FAA, Dalla Corte CL. Mitochondrial function and cellular energy maintenance during aging in a Drosophila melanogaster model of Parkinson Disease. Mitochondrion 2022:S1567-7249(22)00054-X. [PMID: 35787469 DOI: 10.1016/j.mito.2022.06.007] [Reference Citation Analysis]
5 Neves PFR, Milanesi BB, Paz LV, de Miranda Monteiro VAC, Neves LT, da Veiga LC, da Silva RB, Sulzbach JH, Knijkik GP, de Revoredo Ribeiro EC, de Souza Silva EL, Vieira MQ, Bagatini PB, Wieck A, Mestriner RG, Xavier LL. Age-related tolerance to paraquat-induced parkinsonism in Drosophila melanogaster. Toxicology Letters 2022. [DOI: 10.1016/j.toxlet.2022.03.010] [Reference Citation Analysis]
6 Maitra U, Stephen C, Ciesla LM. Drug discovery from natural products - Old problems and novel solutions for the treatment of neurodegenerative diseases. J Pharm Biomed Anal 2021;210:114553. [PMID: 34968995 DOI: 10.1016/j.jpba.2021.114553] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
7 Hernandez-Diaz S, Ghimire S, Sanchez-Mirasierra I, Montecinos-Oliva C, Swerts J, Kuenen S, Verstreken P, Soukup SF. Endophilin-B regulates autophagy during synapse development and neurodegeneration. Neurobiol Dis 2021;163:105595. [PMID: 34933093 DOI: 10.1016/j.nbd.2021.105595] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
8 Wang X, Li Y, He M, Kong X, Jiang P, Liu X, Diao L, Zhang X, Li H, Ling X, Xia S, Liu Z, Liu Y, Cui CP, Wang Y, Tang L, Zhang L, He F, Li D. UbiBrowser 2.0: a comprehensive resource for proteome-wide known and predicted ubiquitin ligase/deubiquitinase-substrate interactions in eukaryotic species. Nucleic Acids Res 2021:gkab962. [PMID: 34669962 DOI: 10.1093/nar/gkab962] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Liu Q, Bautista-Gomez J, Higgins DA, Yu J, Xiong Y. Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegeneration. Sci Signal 2021;14:eabg3555. [PMID: 34315807 DOI: 10.1126/scisignal.abg3555] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
10 Bastioli G, Regoni M, Cazzaniga F, De Luca CMG, Bistaffa E, Zanetti L, Moda F, Valtorta F, Sassone J. Animal Models of Autosomal Recessive Parkinsonism. Biomedicines 2021;9:812. [PMID: 34356877 DOI: 10.3390/biomedicines9070812] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Himalian R, Singh SK, Singh MP. Ameliorative Role of Nutraceuticals on Neurodegenerative Diseases Using the Drosophila melanogaster as a Discovery Model to Define Bioefficacy. J Am Coll Nutr 2021;:1-29. [PMID: 34125661 DOI: 10.1080/07315724.2021.1904305] [Reference Citation Analysis]
12 Pütz SM, Kram J, Rauh E, Kaiser S, Toews R, Lueningschroer-Wang Y, Rieger D, Raabe T. Loss of p21-activated kinase Mbt/PAK4 causes Parkinson-like phenotypes in Drosophila. Dis Model Mech 2021;14:dmm047811. [PMID: 34125184 DOI: 10.1242/dmm.047811] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
13 Walakira A, Rozman D, Režen T, Mraz M, Moškon M. Guided extraction of genome-scale metabolic models for the integration and analysis of omics data. Comput Struct Biotechnol J 2021;19:3521-30. [PMID: 34194675 DOI: 10.1016/j.csbj.2021.06.009] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Aguilar JI, Cheng MH, Font J, Schwartz AC, Ledwitch K, Duran A, Mabry SJ, Belovich AN, Zhu Y, Carter AM, Shi L, Kurian MA, Fenollar-Ferrer C, Meiler J, Ryan RM, Mchaourab HS, Bahar I, Matthies HJ, Galli A. Psychomotor impairments and therapeutic implications revealed by a mutation associated with infantile Parkinsonism-Dystonia. Elife 2021;10:e68039. [PMID: 34002696 DOI: 10.7554/eLife.68039] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Ferrini A, Steel D, Barwick K, Kurian MA. An Update on the Phenotype, Genotype and Neurobiology of ADCY5-Related Disease. Mov Disord 2021;36:1104-14. [PMID: 33934385 DOI: 10.1002/mds.28495] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
16 Vos M, Klein C. The Importance of Drosophila melanogaster Research to UnCover Cellular Pathways Underlying Parkinson's Disease. Cells 2021;10:579. [PMID: 33800736 DOI: 10.3390/cells10030579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
17 Siima AA, Stephano F, Munissi JJE, Nyandoro SS. Ameliorative effects of flavonoids and polyketides on the rotenone induced Drosophila model of Parkinson's disease. Neurotoxicology 2020;81:209-15. [PMID: 32937168 DOI: 10.1016/j.neuro.2020.09.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
18 Blosser JA, Podolsky E, Lee D. L-DOPA-Induced Dyskinesia in a Genetic Drosophila Model of Parkinson's Disease. Exp Neurobiol 2020;29:273-84. [PMID: 32921640 DOI: 10.5607/en20028] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Delos Santos K, Kwon E, Moon NS. PRPS-Associated Disorders and the Drosophila Model of Arts Syndrome. Int J Mol Sci 2020;21:E4824. [PMID: 32650483 DOI: 10.3390/ijms21144824] [Reference Citation Analysis]
20 Brás IC, Dominguez-Meijide A, Gerhardt E, Koss D, Lázaro DF, Santos PI, Vasili E, Xylaki M, Outeiro TF. Synucleinopathies: Where we are and where we need to go. J Neurochem 2020;153:433-54. [PMID: 31957016 DOI: 10.1111/jnc.14965] [Cited by in Crossref: 25] [Cited by in F6Publishing: 39] [Article Influence: 12.5] [Reference Citation Analysis]
21 Rai SN, Singh P. Advancement in the modelling and therapeutics of Parkinson's disease. J Chem Neuroanat 2020;104:101752. [PMID: 31996329 DOI: 10.1016/j.jchemneu.2020.101752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 36] [Article Influence: 4.5] [Reference Citation Analysis]
22 Kilzheimer A, Hentrich T, Burkhardt S, Schulze-Hentrich JM. The Challenge and Opportunity to Diagnose Parkinson's Disease in Midlife. Front Neurol 2019;10:1328. [PMID: 31920948 DOI: 10.3389/fneur.2019.01328] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
23 Gómez IM, Rodríguez MA, Santalla M, Kassis G, Colman Lerner JE, Aranda JO, Sedán D, Andrinolo D, Valverde CA, Ferrero P. Inhalation of marijuana affects Drosophila heart function. Biol Open 2019;8:bio044081. [PMID: 31324618 DOI: 10.1242/bio.044081] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
24 Cheng J, Lu Q, Song L, Ho MS. α-Synuclein Trafficking in Parkinson's Disease: Insights From Fly and Mouse Models. ASN Neuro 2018;10:1759091418812587. [PMID: 30482039 DOI: 10.1177/1759091418812587] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
25 González N, Arcos-López T, König A, Quintanar L, Menacho Márquez M, Outeiro TF, Fernández CO. Effects of alpha-synuclein post-translational modifications on metal binding. J Neurochem 2019;150:507-21. [PMID: 31099098 DOI: 10.1111/jnc.14721] [Cited by in Crossref: 24] [Cited by in F6Publishing: 40] [Article Influence: 8.0] [Reference Citation Analysis]
26 Maitra U, Ciesla L. Using Drosophila as a platform for drug discovery from natural products in Parkinson's disease. Medchemcomm 2019;10:867-79. [PMID: 31303984 DOI: 10.1039/c9md00099b] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
27 Sapar ML, Han C. Die in pieces: How Drosophila sheds light on neurite degeneration and clearance. J Genet Genomics 2019;46:187-99. [PMID: 31080046 DOI: 10.1016/j.jgg.2019.03.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
28 Bajracharya R, Youngson NA, Ballard JWO. Dietary Macronutrient Management to Treat Mitochondrial Dysfunction in Parkinson's Disease. Int J Mol Sci 2019;20:E1850. [PMID: 30991634 DOI: 10.3390/ijms20081850] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
29 Pérez-Moreno JJ, O'Kane CJ. GAL4 Drivers Specific for Type Ib and Type Is Motor Neurons in Drosophila. G3 (Bethesda) 2019;9:453-62. [PMID: 30530644 DOI: 10.1534/g3.118.200809] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
30 Deal SL, Yamamoto S. Unraveling Novel Mechanisms of Neurodegeneration Through a Large-Scale Forward Genetic Screen in Drosophila. Front Genet 2018;9:700. [PMID: 30693015 DOI: 10.3389/fgene.2018.00700] [Cited by in Crossref: 12] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
31 De Lazzari F, Bisaglia M, Zordan MA, Sandrelli F. Circadian Rhythm Abnormalities in Parkinson's Disease from Humans to Flies and Back. Int J Mol Sci 2018;19:E3911. [PMID: 30563246 DOI: 10.3390/ijms19123911] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
32 Nagoshi E. Drosophila Models of Sporadic Parkinson's Disease. Int J Mol Sci 2018;19:E3343. [PMID: 30373150 DOI: 10.3390/ijms19113343] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
33 Solari P, Maccioni R, Marotta R, Catelani T, Debellis D, Baroli B, Peddio S, Muroni P, Kasture S, Solla P, Stoffolano JG Jr, Liscia A. The imbalance of serotonergic circuitry impairing the crop supercontractile muscle activity and the mitochondrial morphology of PD PINK1B9Drosophila melanogaster are rescued by Mucuna pruriens. J Insect Physiol 2018;111:32-40. [PMID: 30393142 DOI: 10.1016/j.jinsphys.2018.10.007] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
34 Khanam S, Naz F, Ali F, Smita Jyoti R, Fatima A, Khan W, Singh BR, Naqvi AH, Siddique YH. Effect of cabergoline alginate nanocomposite on the transgenic Drosophila melanogaster model of Parkinson’s disease. Toxicology Mechanisms and Methods 2018;28:699-708. [DOI: 10.1080/15376516.2018.1502386] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]